|
FEM1B expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.1828999996476E-07 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.45989999977836E-07 |
| Normal-vs-Stage2 |
2.791400E-04 |
| Normal-vs-Stage3 |
9.675500E-03 |
| Normal-vs-Stage4 |
2.042200E-02 |
| Stage1-vs-Stage2 |
8.409800E-01 |
| Stage1-vs-Stage3 |
3.896200E-01 |
| Stage1-vs-Stage4 |
6.920600E-01 |
| Stage2-vs-Stage3 |
6.302800E-01 |
| Stage2-vs-Stage4 |
6.056200E-01 |
| Stage3-vs-Stage4 |
4.311800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.45469999566362E-08 |
| Normal-vs-AfricanAmerican |
6.1599999999995E-05 |
| Normal-vs-Asian |
9.923900E-03 |
| Caucasian-vs-AfricanAmerican |
6.509600E-01 |
| Caucasian-vs-Asian |
8.760800E-01 |
| AfricanAmerican-vs-Asian |
7.703600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.34519994721938E-09 |
| Normal-vs-Female |
2.310000E-02 |
| Male-vs-Female |
4.100800E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.481530E-03 |
| Normal-vs-Extreme_Weight |
3.61550001048982E-09 |
| Normal-vs-Obese |
1.230370E-04 |
| Normal-vs-Extreme_Obese |
5.377300E-04 |
| Normal_Weight-vs-Extreme_Weight |
2.317600E-01 |
| Normal_Weight-vs-Obese |
7.955400E-01 |
| Normal_Weight-vs-Extreme_Obese |
7.096000E-01 |
| Extreme_Weight-vs-Obese |
4.305800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.118200E-01 |
| Obese-vs-Extreme_Obese |
5.017000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.409700E-04 |
| Normal-vs-Age(41-60Yrs) |
7.6608000000089E-05 |
| Normal-vs-Age(61-80Yrs) |
1.89019999652373E-08 |
| Normal-vs-Age(81-100Yrs) |
6.57750000021551E-07 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.442200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.698000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.384390E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.757700E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.298500E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.436200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.34860000336568E-08 |
| Normal-VS-Type2 PRCC |
3.85350000000617E-05 |
| Normal-VS-KIRP CIMP |
7.974300E-04 |
| Normal-VS-Unclassified PRCC |
2.533800E-02 |
| Type1 PRCC-VS-Type2 PRCC |
5.912800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
9.918200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.856100E-02 |
| Type2 PRCC-VS-KIRP CIMP |
8.166200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.839400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.712000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
5.93279980698469E-10 |
| Normal-vs-N1 |
1.725970E-02 |
| Normal-vs-N2 |
3.418600E-03 |
| N0-vs-N1 |
9.531500E-02 |
| N0-vs-N2 |
7.485400E-01 |
| N1-vs-N2 |
3.680000E-01 |
|
|
